BCL2L1 and glioblastoma: Importantly, inhibitors of Bcl-2/Bcl-xl along with Mcl-1 inhibitors in a nanoparticle format has shown efficacy in animal model system in crossing the blood-brain barrier and suppressing the growth of glioblastoma [37].